NASDAQ | ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.11% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.52% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 6.35% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.38% |
AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 3.47% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.68% |
ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.70% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.66% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.52% |
SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.30% |
RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.24% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.17% |
UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.14% |
INSM | Insmed Inc | Healthcare | Biotechnology | 1.12% |
ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.02% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.00% |
INCY | Incyte Corporation | Healthcare | Biotechnology | 0.98% |
KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 0.92% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 0.90% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.89% |